絞り込み

16645

広告

Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing.

著者 Mishra A , Emamgholi F , Erlangga Z , Hartleben B , Unger K , Wolff K , Teichmann U , Kessel M , Woller N , Kühnel F , Dow LE , Manns MP , Vogel A , Lowe SW , Saborowski A , Saborowski M
Carcinogenesis.2019 Jun 06 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

Beyond the nearly uniform presence of KRAS mutations, pancreatic cancer is increasingly recognized as a heterogeneous disease. Pre-clinical in vivo model systems exist, but with the advent of precision oncology, murine models with enhanced genetic flexibility are needed to functionally annotate genetic alterations found in the human malignancy. Here, we describe the generation of focal gene disruptions and large chromosomal deletions via inducible and pancreas specific expression of Cas9 in adult mice. Experimental mice are derived on demand directly from genetically engineered embryonic stem cells, without the need for further intercrossing. To provide initial validation of our approach, we show that disruption of the E3 ubiquitin ligase Rnf43 accelerates KrasG12D-dependent tumourigenesis. Moreover, we demonstrate that this system can be used to rapidly interrogate the impact of complex cancer-associated alleles through the generation of a previously unstudied 1.2 megabase deletion surrounding the CKDN2A and CDKN2B tumour suppressors. Thus, our approach is capable of reproducibly generating biallelic and precise loss of large chromosomal fragments that, in conjunction with mutant Kras, leads to development of pancreatic ductal adenocarcinoma with full penetrance.
PMID: 31170286 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード